The number of people affected by the long COVID continues to increase as doctors begin to understand how to identify these patients and develop a multidisciplinary treatment plan to address the various symptoms.
September 30, 2021
Post-acute sequelae of SARS-CoV-2 infection (PASC), commonly referred to as Long COVID, is a term used for patients who have recovered from acute COVID but have symptoms that persist for weeks or months. The number of people affected by the long COVID continues to increase as doctors begin to understand how to identify these patients and develop a multidisciplinary treatment plan to address the various symptoms. In search of answers, Labcorp is pleased to announce a series of webinars dedicated to the next pandemic, long COVID. In this series, speakers will explore different topics specific to Long COVID that impact patients, physicians, as well as drug development companies.
In the first of our series, speakers will explore the dizzying world of Postural Orthostatic Tachycardia Syndrome (POTS). POTS has traditionally been a highly symptomatic, potentially debilitating, often misunderstood medical condition, and is notoriously difficult to treat. Now, in the wake of the COVID pandemic, new light has been shed on POTS as the population of patients diagnosed with the disease continues to rise.
Join this webinar to hear from two key opinion leaders in the field as we explore the symptoms, diagnosis and potential mechanisms of post-COVID POTS as well as consider a framework for therapy.
Join Artur Fedorowski, MD, PhD, Senior Consultant and Head of Syncope Unit, Department of Cardiology, Karolinska University Hospital; Brian Olshansky, MD, clinical cardiac electrophysiologist, Carleton College and University of Arizona School of Medicine; and Oren Cohen, MD, Chief of Clinical Pharmacology Services and Medical Director, Labcorp Drug Development, for the live webinar Monday October 18, 2021 at 11 a.m. EDT (4 p.m. BST / UK).
For more information or to register for this event, visit The Dizzying World of Post-COVID Jars: Symptoms, Potential Mechanisms, and Therapies.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars for the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private and academic research institutes, health centers, etc.) turn to Xtalks for access quality content. Xtalks helps life science professionals stay on top of industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from key industry thought leaders and service providers.
Share the article on social media or by email: